caffeic acid phenethyl ester has been researched along with chrysin in 8 studies
Studies (caffeic acid phenethyl ester) | Trials (caffeic acid phenethyl ester) | Recent Studies (post-2010) (caffeic acid phenethyl ester) | Studies (chrysin) | Trials (chrysin) | Recent Studies (post-2010) (chrysin) |
---|---|---|---|---|---|
840 | 1 | 469 | 913 | 6 | 646 |
Protein | Taxonomy | caffeic acid phenethyl ester (IC50) | chrysin (IC50) |
---|---|---|---|
G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | 7.1 | |
Cytochrome P450 1A1 | Homo sapiens (human) | 0.7215 | |
Cytochrome P450 1A2 | Homo sapiens (human) | 0.236 | |
Cyclin-dependent kinase 1 | Homo sapiens (human) | 7.1 | |
Aromatase | Homo sapiens (human) | 0.667 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 5.225 | |
G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 7.1 | |
Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 8.14 | |
G2/mitotic-specific cyclin-B | Marthasterias glacialis (spiny starfish) | 5.85 | |
Aldo-keto reductase family 1 member B1 | Bos taurus (cattle) | 7.79 | |
Carbonyl reductase [NADPH] 1 | Homo sapiens (human) | 0.67 | |
Glycogen synthase kinase-3 beta | Rattus norvegicus (Norway rat) | 5.85 | |
Casein kinase II subunit alpha' | Homo sapiens (human) | 9 | |
Amine oxidase [flavin-containing] A | Homo sapiens (human) | 1.6 | |
Amine oxidase [flavin-containing] B | Homo sapiens (human) | 1.6 | |
Proteasome subunit beta type-5 | Homo sapiens (human) | 5.5 | |
Xanthine dehydrogenase/oxidase | Homo sapiens (human) | 0.84 | |
Glycogen synthase kinase-3 alpha | Homo sapiens (human) | 7.2 | |
Glycogen synthase kinase-3 beta | Homo sapiens (human) | 7.2 | |
Casein kinase II subunit beta | Homo sapiens (human) | 9 | |
Casein kinase II subunit alpha | Homo sapiens (human) | 9 | |
Xanthine dehydrogenase/oxidase | Bos taurus (cattle) | 1.26 | |
Cyclin-dependent kinase 6 | Homo sapiens (human) | 5.88 | |
Cyclin-dependent-like kinase 5 | Homo sapiens (human) | 5.3 | |
Cyclin homolog | Herpesvirus saimiri (strain 11) | 5.85 | |
Cyclin-dependent kinase 5 activator 1 | Homo sapiens (human) | 5.3 | |
Cytochrome P450 1B1 | Homo sapiens (human) | 0.152 | |
Integrase | Human immunodeficiency virus 1 | 1.4 | |
Casein kinase II subunit alpha 3 | Homo sapiens (human) | 9 | |
G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | 7.1 | |
3-oxoacyl-acyl-carrier protein reductase | Plasmodium falciparum (malaria parasite P. falciparum) | 10 | |
Cyclin-dependent kinase 1 | Oryzias latipes (Japanese medaka) | 5.85 | |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 2.05 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Banskota, AH; Kadota, S; Matsushige, K; Midorikawa, K; Tezuka, Y; Usia, T | 1 |
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Fallarero, A; Hanski, L; Isojärvi, J; Karhu, E; Vuorela, P | 1 |
Nishioka, N; Tsuji, T; Yoshizumi, K | 1 |
Borawska, MH; Car, H; Chyczewski, L; Isidorov, V; Markiewicz-Żukowska, R; Naliwajko, SK; Sawicka, D; Szynaka, B | 1 |
Al-Amiery, AA; Bagnati, R; Sulaiman, GM | 1 |
Alday, E; Alday-Provencio, S; Astiazaran, H; Diaz, G; Garibay-Escobar, A; Hernandez, J; Quintero, J; Rascon, L; Robles-Zepeda, R; Velazquez, C | 1 |
Belduz, AO; Guler, HI; Kolayli, S; Tatar, G; Yildiz, O | 1 |
8 other study(ies) available for caffeic acid phenethyl ester and chrysin
Article | Year |
---|---|
Constituents of Chinese propolis and their antiproliferative activities.
Topics: Animals; Antineoplastic Agents; Biphenyl Compounds; Caffeic Acids; China; Chromatography, Thin Layer; Colonic Neoplasms; Drug Screening Assays, Antitumor; Flavonoids; Free Radical Scavengers; Mice; Molecular Structure; Phenylethyl Alcohol; Picrates; Propolis; Spectrophotometry, Infrared; Tumor Cells, Cultured | 2002 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Identification of Privileged Antichlamydial Natural Products by a Ligand-Based Strategy.
Topics: Anti-Bacterial Agents; Azithromycin; Biological Products; Cell Line; Cell Survival; Chlamydophila pneumoniae; Drug Discovery; Humans; Ligands; Microbial Sensitivity Tests; Molecular Structure | 2017 |
[Xanthine oxidase inhibitory activity and hypouricemia effect of propolis in rats].
Topics: Animals; Anti-Infective Agents; Brazil; Caffeic Acids; China; Coumaric Acids; Disease Models, Animal; Flavonoids; Gout; Hyperuricemia; Male; Oxonic Acid; Phenylethyl Alcohol; Phenylpropionates; Propionates; Propolis; Rats; Rats, Sprague-Dawley; Uric Acid; Xanthine Oxidase | 2005 |
Ethanolic extract of propolis, chrysin, CAPE inhibit human astroglia cells.
Topics: Apoptosis; Astrocytes; Caffeic Acids; Cell Line; Cell Survival; Cytotoxins; Ethanol; Flavonoids; Humans; Phenylethyl Alcohol; Propolis | 2012 |
Theoretical, antioxidant and cytotoxic activities of caffeic acid phenethyl ester and chrysin.
Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Caffeic Acids; Cell Proliferation; Cell Survival; Computational Biology; Flavonoids; Free Radical Scavengers; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Models, Chemical; Phenylethyl Alcohol; Quantum Theory; Structure-Activity Relationship | 2014 |
Sonoran propolis and some of its chemical constituents inhibit in vitro growth of Giardia lamblia trophozoites.
Topics: Animals; Caffeic Acids; Cell Proliferation; Flavonoids; Giardia lamblia; Mexico; Phenylethyl Alcohol; Propolis; Rutin; Trophozoites | 2015 |
Investigation of potential inhibitor properties of ethanolic propolis extracts against ACE-II receptors for COVID-19 treatment by molecular docking study.
Topics: Angiotensin-Converting Enzyme 2; Animals; Bees; Caffeic Acids; COVID-19 Drug Treatment; Flavanones; Flavonoids; Hesperidin; Humans; Luteolin; Molecular Docking Simulation; Phenylethyl Alcohol; Plant Extracts; Propolis; Quercetin; Rutin | 2021 |